Results 11 to 20 of about 481,863 (320)

CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma

open access: yesFrontiers in Cell and Developmental Biology, 2021
Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) has been reported to be dysregulated in a variety of cancers and seems to play paradoxical roles in different cancers.
Jiehui Di   +16 more
doaj   +1 more source

Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression

open access: yesNature Communications, 2022
A major obstacle in diabetes is the metabolic or hyperglycemic memory, which lacks specific therapies. Here we show that glucose-mediated changes in gene expression largely persist in diabetic kidney disease (DKD) despite reversing hyperglycemia.
M. M. Al-Dabet   +24 more
semanticscholar   +1 more source

Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2

open access: yesNature Communications, 2021
Since their discovery as drivers of proliferation, cyclin-dependent kinases (CDKs) have been considered therapeutic targets. Small molecule inhibitors of CDK4/6 are used and tested in clinical trials to treat multiple cancer types. Despite their clinical

semanticscholar   +1 more source

AUF1 ligand circPCNX reduces cell proliferation by competing with p21 mRNA to increase p21 production.

open access: yesNucleic Acids Research, 2021
Mammalian circRNAs can influence different cellular processes by interacting with proteins and other nucleic acids. Here, we used ribonucleoprotein immunoprecipitation (RIP) analysis to identify systematically the circRNAs associated with the cancer ...
Dimitrios Tsitsipatis   +14 more
semanticscholar   +1 more source

Role of P21 in Resistance of Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2020
Lung cancer is the most common malignant tumor in the world with the highest incidence of deaths. In recent years, the treatment of lung cancer has made a significant breakthrough.
Tian FU, Ailing LIANG, Yongjun LIU
doaj   +1 more source

Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells

open access: yesFrontiers in Oncology, 2020
Abnormal histone deacetylase (HDAC) expression is closely related to cancer development and progression. Many HDAC inhibitors have been widely used in cancer treatment; however, severe side effects often limit their clinical application.
Chi-Yuan Chen   +14 more
doaj   +1 more source

The NUCKS1-SKP2-p21/p27 axis controls S phase entry

open access: yesNature Communications, 2021
Efficient entry into S phase of the cell cycle is necessary for embryonic development and tissue homoeostasis. However, unscheduled S phase entry triggers DNA damage and promotes oncogenesis, underlining the requirement for strict control.
Samuel Hume   +6 more
semanticscholar   +1 more source

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma

open access: yesCancer Biology & Medicine, 2020
Objective: The E3 ligase, CRL4, plays diverse roles in different cellular processes, such as DNA damage, transcriptional regulation, cell cycle progression, and cell apoptosis.
Ting Li   +6 more
doaj   +1 more source

Repeated Administration of Cisplatin Transforms Kidney Fibroblasts through G2/M Arrest and Cellular Senescence

open access: yesCells, 2022
Cisplatin is a potent chemotherapeutic used for the treatment of many types of cancer, but it has nephrotoxic side effects leading to acute kidney injury and subsequently chronic kidney disease (CKD).
Jia-Bin Yu   +3 more
doaj   +1 more source

Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter [PDF]

open access: yes, 2002
Although the promoters of both the Bax and p21 genes are activated by p53, they differ in the effect on this activation of the POU family transcription factor Brn-3a. Thus, Brn-3a inhibits activation of the Bax promoter by p53 but enhances the ability of
Budhram-Mahadeo, VS   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy